The UK’s Medicines and Healthcare products Regulatory Agency (MHRA), Advertising Standards Authority (ASA), and General Pharmaceutical Council (GPhC) have announced a joint enforcement action targeting businesses illegally promoting weight-loss medicines. The coordinated warning addresses two primary concerns: the unlicensed sale of products lacking regulatory approval, and misleading marketing claims surrounding newly authorised prescription-only drugs.
This unified regulatory response reflects growing concern about consumer protection in the weight-loss medication sector. The three agencies, which collectively oversee drug safety, advertising standards, and pharmacy conduct, are urging the public to obtain weight-loss medications exclusively from licensed pharmacies with valid prescriptions. Patients and healthcare professionals are encouraged to report suspicious sellers and unlicensed product advertisements directly to the ASA or MHRA.
The enforcement action underscores the importance of adhering to UK pharmaceutical promotion rules and consumer protection legislation. Read the full article on GMJ Newsroom.
Was this article helpful?
